A growing market with shrinking venture funding means FemTech brands have to grow on revenue, not on fresh capital. That changes what a healthcare growth partner should do: fewer expensive experiments, more channels that compound and can be tied to sales.
Wellness Marketing Reports' own research points the same way. In its interviews with 63 founders, 78% named digital censorship as their top growth inhibitor, and traditional ads under medical censorship commonly returned below 1.0 ROAS. The channels that held up (partnerships, education, podcasts) are also the cheaper ones to sustain.
Read the FemTech marketing channel playbooks or return to the FemTech marketing agency overview.